Nabanita Das
Bijnor Sisendi Road
Lucknow, UP 226002, India
Lucknow, UP 226002, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A Novel Small-Molecule Dual Adiponectin Receptor 1/2 Agonist Induces Myogenesis and Ameliorates Skeletal Muscle Atrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: January 29, 2026
Lactoferrin-Anchored Carboxymethyl Pullulan-MgO Nanocomposites for Targeted Delivery of Trans-Ferulic Acid: Physicochemical Characterization, In vitro and Ex vivo Studies.
Journal: ACS applied bio materials
Published: June 21, 2025
Apigenin-6-C-glucoside ameliorates MASLD in rodent models via selective agonism of adiponectin receptor 2.
Journal: European journal of pharmacology
Published: January 30, 2024
Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences.
Journal: Molecular neurobiology
Published: October 28, 2023
Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine.
Journal: Veterinary research communications
Published: April 28, 2023
Lipid-induced alteration in retinoic acid signaling leads to mitochondrial dysfunction in HepG2 and Huh7 cells.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: February 14, 2023
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression.
Journal: Molecular and cellular endocrinology
Published: August 26, 2021
Adiponectin receptors by increasing mitochondrial biogenesis and respiration promote osteoblast differentiation: Discovery of isovitexin as a new class of small molecule adiponectin receptor modulator with potential osteoanabolic function.
Journal: European journal of pharmacology
Published: August 15, 2021
Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents.
Journal: Metabolism: clinical and experimental
Published: July 19, 2019
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells.
Journal: Haematologica
Published: April 11, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026